Principles of V.A.C.® Therapy
V.A.C.® Therapy in the treatment of diabetic foot
Introduced in 1995 by KCI (Kinetic Concepts, Inc.), V.A.C.® Therapy has helped treat more than 1.5 million patients worldwide for a wide variety of wound types, such as pressure ulcers, diabetic, abdominal and trauma wounds, flaps and grafts, and partial thickness burns.
The V.A.C.® System delivers Negative Pressure Wound Therapy (NPWT) through multiple mechanisms of action to help promote wound healing, using three key components: GranuFoam® or V.A.C.® WhiteFoam dressings, SensaT.R.A.C.® Technology, and the V.A.C.® Therapy unit. These work in unison to prepare the wound bed for closure, reduce oedema, promote granulation tissue formation and perfusion, and remove exudate and infectious material.
V.A.C.® Therapy's clinical benefits and economic value are supported by an extensive body of medical evidence including 14 randomized controlled trials, more than 361 peer-reviewed publications and citations in more than 59 medical text books. Most recently, KCI announced the results of the largest randomized controlled trial on the use of V.A.C.® Therapy in the treatment of the diabetic foot. The study involved 342 patients across 37 participating centers and demonstrated that V.A.C.® Therapy significantly increased the number of wounds achieving complete closure as well as a reduction in the time required to achieve wound healing.
V.A.C.® Therapy training coming soon
Venue, date and time to be confirmed
Abstracts - RCT's
- Interim results of a randomized, controlled multicenter trial of vacuum-assisted closure therapy* in the treatment
and blinded evaluation of diabetic foot ulcers
Peter A. Blume, DPM1; Bauer E. Sumpio, MD, PhD2; 1North American Center for Limb Preservation, 2Dept of Vascular Surgery, Yale University School of Medicine
Symposium for Advanced Wound Care (SAWC), Tampa, Florida, April 28 - May 1 2007 - Diabetic foot ulcer and VAC resource utilization and economic cost based on a randomized trial
Jan Apelqvist; David G. Armstrong; Lawrence A. Lavery; Andrew JM. Boulton; Dr.William M. Scholl College of Podiatric Medicine
Symposium for Advanced Wound Care (SAWC), Tampa, Florida, April 28 - May 1 2007 - Negative Pressure Wound Therapy after partial diabetic foot amputation: a multicentre, randomised controlled
trial
Armstrong D.G., Lavery L.A., Lancet 2005; 366:1704-10(Study funded by KCI.) - Consensus Statement on Negative Pressure Wound Therapy (V.A.C.® Therapy) for the Management of Diabetic Foot Wounds.
Andros G et al., Ostomy Wound Management. 2006 June; 52(6) Supplement
For further information please visit www.kci-medical.com
*V.A.C.® Therapy, KCI USA, San Antonio, Texas
